Associations between social connections and cognition: a global collaborative individual participant data meta-analysis.


Journal

The lancet. Healthy longevity
ISSN: 2666-7568
Titre abrégé: Lancet Healthy Longev
Pays: England
ID NLM: 101773309

Informations de publication

Date de publication:
11 2022
Historique:
received: 19 05 2022
revised: 16 08 2022
accepted: 19 08 2022
pubmed: 24 10 2022
medline: 15 11 2022
entrez: 23 10 2022
Statut: ppublish

Résumé

Poor social connections (eg, small networks, infrequent interactions, and loneliness) are modifiable risk factors for cognitive decline. Existing meta-analyses are limited by reporting aggregate responses, a focus on global cognition, and combining social measures into single constructs. We aimed to investigate the association between social connection markers and the rate of annual change in cognition (ie, global and domain-specific), as well as sex differences, using an individual participant data meta-analysis. We harmonised data from 13 longitudinal cohort studies of ageing in North America, South America, Europe, Africa, Asia, and Australia. Studies were eligible for inclusion if they had baseline data for social connection markers and at least two waves of cognitive scores. Follow-up periods ranged from 0 years to 15 years across cohorts. We included participants with cognitive data for at least two waves and social connection data for at least one wave. We then identified and excluded people with dementia at baseline. Primary outcomes were annual rates of change in global cognition and cognitive domain scores over time until final follow-up within each cohort study analysed by use of an individual participant data meta-analysis. Linear mixed models within cohorts used baseline social connection markers as predictors of the primary outcomes. Effects were pooled in two stages using random-effects meta-analyses. We assessed the primary outcomes in the main (partially adjusted) and fully adjusted models. Partially adjusted models controlled for age, sex, and education; fully adjusted models additionally controlled for diabetes, hypertension, smoking, cardiovascular risk, and depression. Of the 40 006 participants in the 13 cohort studies, we excluded 1392 people with dementia at baseline. 38 614 individual participants were included in our analyses. For the main models, being in a relationship or married predicted slower global cognitive decline (b=0·010, 95% CI 0·000-0·019) than did being single or never married; living with others predicted slower global cognitive (b=0·007, 0·002-0·012), memory (b=0·017, 0·006-0·028), and language (b=0·008, 0·000-0·015) decline than did living alone; and weekly interactions with family and friends (b=0·016, 0·006-0·026) and weekly community group engagement (b=0·030, 0·007-0·052) predicted slower memory decline than did no interactions and no engagement. Never feeling lonely predicted slower global cognitive (b=0·047, 95% CI 0·018-0·075) and executive function (b=0·047, 0·017-0·077) decline than did often feeling lonely. Degree of social support, having a confidante, and relationship satisfaction did not predict cognitive decline across global cognition or cognitive domains. Heterogeneity was low (I Good social connections (ie, living with others, weekly community group engagement, interacting weekly with family and friends, and never feeling lonely) are associated with slower cognitive decline. EU Joint Programme-Neurodegenerative Disease Research grant, funded by the National Health and Medical Research Council Australia, and the US National Institute on Aging of the US National Institutes of Health.

Sections du résumé

BACKGROUND
Poor social connections (eg, small networks, infrequent interactions, and loneliness) are modifiable risk factors for cognitive decline. Existing meta-analyses are limited by reporting aggregate responses, a focus on global cognition, and combining social measures into single constructs. We aimed to investigate the association between social connection markers and the rate of annual change in cognition (ie, global and domain-specific), as well as sex differences, using an individual participant data meta-analysis.
METHODS
We harmonised data from 13 longitudinal cohort studies of ageing in North America, South America, Europe, Africa, Asia, and Australia. Studies were eligible for inclusion if they had baseline data for social connection markers and at least two waves of cognitive scores. Follow-up periods ranged from 0 years to 15 years across cohorts. We included participants with cognitive data for at least two waves and social connection data for at least one wave. We then identified and excluded people with dementia at baseline. Primary outcomes were annual rates of change in global cognition and cognitive domain scores over time until final follow-up within each cohort study analysed by use of an individual participant data meta-analysis. Linear mixed models within cohorts used baseline social connection markers as predictors of the primary outcomes. Effects were pooled in two stages using random-effects meta-analyses. We assessed the primary outcomes in the main (partially adjusted) and fully adjusted models. Partially adjusted models controlled for age, sex, and education; fully adjusted models additionally controlled for diabetes, hypertension, smoking, cardiovascular risk, and depression.
FINDINGS
Of the 40 006 participants in the 13 cohort studies, we excluded 1392 people with dementia at baseline. 38 614 individual participants were included in our analyses. For the main models, being in a relationship or married predicted slower global cognitive decline (b=0·010, 95% CI 0·000-0·019) than did being single or never married; living with others predicted slower global cognitive (b=0·007, 0·002-0·012), memory (b=0·017, 0·006-0·028), and language (b=0·008, 0·000-0·015) decline than did living alone; and weekly interactions with family and friends (b=0·016, 0·006-0·026) and weekly community group engagement (b=0·030, 0·007-0·052) predicted slower memory decline than did no interactions and no engagement. Never feeling lonely predicted slower global cognitive (b=0·047, 95% CI 0·018-0·075) and executive function (b=0·047, 0·017-0·077) decline than did often feeling lonely. Degree of social support, having a confidante, and relationship satisfaction did not predict cognitive decline across global cognition or cognitive domains. Heterogeneity was low (I
INTERPRETATION
Good social connections (ie, living with others, weekly community group engagement, interacting weekly with family and friends, and never feeling lonely) are associated with slower cognitive decline.
FUNDING
EU Joint Programme-Neurodegenerative Disease Research grant, funded by the National Health and Medical Research Council Australia, and the US National Institute on Aging of the US National Institutes of Health.

Identifiants

pubmed: 36273484
pii: S2666-7568(22)00199-4
doi: 10.1016/S2666-7568(22)00199-4
pmc: PMC9750173
mid: NIHMS1848634
pii:
doi:

Types de publication

Meta-Analysis Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e740-e753

Subventions

Organisme : NIA NIH HHS
ID : RF1 AG057531
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG023651
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG017644
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00019/3
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R21 AG045722
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG022838
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023651
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests HB declares consulting fees from Biogen; advisory board fees from Nutricia, Roche, Skin2Neuron, and Cranbrook Care; and grant funding through the EU Joint Programme–Neurodegenerative Disease Research (JPND) from the National Health and Medical Research Council Australia. DML declares funding to their institution by the US National Institute on Aging–National Institutes of Health (NIA–NIH) award (number RF1AG05753 1RF1AG057531–01). RM declares funding from the JPND. HW declares a research grant from the JPND for the SHARED project (grant number HESOCARE-329–109). PSS declares payments for advisory board meetings for Biogen Australia and Roche Australia, and funding to the university for another cohort study (OATS), unrelated to the submitted work. SSa declares payments for lectures from New York University Sydney and University of Sydney; grant funding from the Dementia Australia Research Foundation, unrelated to the submitted work; and grant funding from the JPND and National Health and Medical Research Council Australia. NS declares that they are the chair of the data safety monitoring board for a study funded by the NIH at Albert Einstein College of Medicine. DS declares funding under the aegis of the JPND (National Center for Research and Development in Poland, project number JPND/06/2020). JM declares funding as part of the SHARED consortium, a JPND that is supported by the Alzheimer's Society (reference 469) in the UK. All other authors declare no competing interests.

Références

BMJ. 2011 Jul 26;343:d4163
pubmed: 21791490
Aging Ment Health. 2021 Feb;25(2):206-212
pubmed: 31771338
J Gerontol B Psychol Sci Soc Sci. 2017 Jan;72(1):16-24
pubmed: 27974472
Int J Environ Res Public Health. 2019 Jan 16;16(2):
pubmed: 30654459
PLoS Med. 2017 Mar 21;14(3):e1002261
pubmed: 28323832
Arch Gen Psychiatry. 2010 Mar;67(3):304-10
pubmed: 20194831
Int J Environ Res Public Health. 2019 Aug 12;16(16):
pubmed: 31408955
Shanghai Arch Psychiatry. 2013 Apr;25(2):91-8
pubmed: 24991140
Am J Epidemiol. 2017 Oct 1;186(7):787-795
pubmed: 28520853
J Health Soc Behav. 2018 Sep;59(3):352-370
pubmed: 30058378
Syst Rev. 2017 Dec 19;6(1):259
pubmed: 29258596
Int Psychogeriatr. 2016 May;28(5):701-3
pubmed: 26955802
Int Psychogeriatr. 2010 Dec;22(8):1248-64
pubmed: 20637138
Z Gerontol Geriatr. 2002 Dec;35(6):575-81
pubmed: 12491004
Psychol Methods. 2002 Jun;7(2):147-77
pubmed: 12090408
Lancet Neurol. 2012 Nov;11(11):1006-12
pubmed: 23079557
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Res Aging. 2004;26(6):655-672
pubmed: 18504506
Stat Med. 2012 Dec 20;31(29):3805-20
pubmed: 22763950
Br J Psychiatry. 2001 Sep;179:250-4
pubmed: 11532803
Int J Epidemiol. 2016 Aug;45(4):1169-1206
pubmed: 27272181
J Gerontol B Psychol Sci Soc Sci. 2021 Oct 30;76(9):1716-1725
pubmed: 33159521
Alzheimers Dement. 2022 May;18(5):934-941
pubmed: 34482619
Aging Clin Exp Res. 2016 Dec;28(6):1089-1104
pubmed: 26670602
J Gerontol B Psychol Sci Soc Sci. 2020 Jan 14;75(2):367-376
pubmed: 31781769
J Alzheimers Dis. 2022;85(1):295-308
pubmed: 34842183
Int Psychogeriatr. 2008 Apr;20(2):237-51
pubmed: 18190728
Pers Soc Psychol Bull. 2008 Feb;34(2):248-59
pubmed: 18212333
Curr Opin Psychol. 2022 Feb;43:232-237
pubmed: 34438331
Springerplus. 2014 Jul 03;3:338
pubmed: 25045613
Int J Epidemiol. 2011 Aug;40(4):862-7
pubmed: 20805109
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Psychiatry Investig. 2018 Aug;15(8):767-774
pubmed: 30086611
Int Psychogeriatr. 2017 Aug;29(8):1317-1325
pubmed: 28511740
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Sci Rep. 2021 Apr 8;11(1):7710
pubmed: 33833259
Soc Sci Med. 2019 May;229:87-95
pubmed: 30177360
JAMA Netw Open. 2021 Feb 1;4(2):e210169
pubmed: 33630089
Neuroepidemiology. 2014;43(1):9-14
pubmed: 24993387
Int J Geriatr Psychiatry. 2009 Nov;24(11):1277-84
pubmed: 19340894

Auteurs

Suraj Samtani (S)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia. Electronic address: s.samtani@unsw.edu.au.

Gowsaly Mahalingam (G)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

Ben Chun Pan Lam (BCP)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

Darren M Lipnicki (DM)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

Maria Fernanda Lima-Costa (MF)

Center for Studies in Public Health and Aging, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.

Sergio Luís Blay (SL)

Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.

Erico Castro-Costa (E)

Center for Studies in Public Health and Aging, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.

Xiao Shifu (X)

Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Maëlenn Guerchet (M)

Inserm U1094, IRD UMR270, University of Limoges, CHU Limoges, Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.

Pierre-Marie Preux (PM)

Inserm U1094, IRD UMR270, University of Limoges, CHU Limoges, Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.

Antoine Gbessemehlan (A)

Inserm U1094, IRD UMR270, University of Limoges, CHU Limoges, Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.

Ingmar Skoog (I)

Department of Psychiatry and Neurochemistry, Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health, University of Gothenburg, Mölndal, Sweden; Psychiatry, Cognition and Old Age Psychiatry Clinic, Sahlgrenska University Hospital, Gothenburg, Sweden.

Jenna Najar (J)

Department of Psychiatry and Neurochemistry, Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health, University of Gothenburg, Mölndal, Sweden; Psychiatry, Cognition and Old Age Psychiatry Clinic, Sahlgrenska University Hospital, Gothenburg, Sweden.

Therese Rydberg Sterner (T)

Department of Psychiatry and Neurochemistry, Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health, University of Gothenburg, Mölndal, Sweden.

Nikolaos Scarmeas (N)

1st Department of Neurology, Aiginition University Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece; Taub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.

Ki-Woong Kim (KW)

Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, South Korea; Department of Psychiatry, Seoul National University College of Medicine and Department of Brain and Cognitive Science, College of Natural Sciences, Seoul National University, Seoul, South Korea.

Steffi Riedel-Heller (S)

Institute of Social Medicine, Occupational Health and Public Health, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Susanne Röhr (S)

Institute of Social Medicine, Occupational Health and Public Health, Faculty of Medicine, University of Leipzig, Leipzig, Germany; Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Alexander Pabst (A)

Institute of Social Medicine, Occupational Health and Public Health, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Suzana Shahar (S)

Centre for Healthy Aging and Wellness, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Katya Numbers (K)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

Mary Ganguli (M)

Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Epidemiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Erin Jacobsen (E)

Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Tiffany F Hughes (TF)

Department of Sociology, Anthropology, and Gerontology, Youngstown State University, Youngstown, OH, USA.

Michael Crowe (M)

Department of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.

Tze Pin Ng (TP)

Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Jane Maddock (J)

MRC Unit for Lifelong Health and Ageing, University College London, London, UK.

Anna Marseglia (A)

Division of Clinical Geriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

René Mélis (R)

Department of Geriatrics, Radboud University Medical Centre, Nijmegen, Netherlands.

Dorota Szcześniak (D)

Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland.

Henrik Wiegelmann (H)

Department of Health Care Research, Institute of Public Health and Nursing Research, University of Bremen, Bremen, Germany.

Myrra Vernooij-Dassen (M)

Faculty of Medical Sciences, Radboud University, Nijmegen, Netherlands.

Yun-Hee Jeon (YH)

Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Perminder S Sachdev (PS)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

Henry Brodaty (H)

Centre for Healthy Brain Ageing, Discipline of Psychiatry, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH